EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multimodal Validation and Disease Stage Dependency of ATTR Cardiomyopathy Red Flags in Patients With LV Thickening

Jakub Piwowarski iD, Jan Gröschel iD, Elena Romero Dorta, Jeanette Schulz-Menger iD, Isabel Mattig iD, Jasmin Zernikow, Christoph Wetz, Vera von Landenberg-Roberg, Bettina Heidecker, Stefanie M Werhahn, Paul J Wetzel, Nicolas W Wieder und 6 weitere

ESC Heart Failure · 13.11.2026

DOI: 10.1093/eschf/xvag285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 13.11.2026. Verfasst von Jakub Piwowarski und 17 weiteren Autor:innen. Beteiligte Einrichtung: Deutsches Herzzentrum der Charité (DHZC), Department of Cardiology, Angiology and Intensive Care Medicine, Campus Charité Mitte, Charitéplatz 1, 1011…. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Timely diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) is critical to improving outcomes and remains challenging. Guidelines recommend assessing for red flags (RFs) to facilitate ATTR-CM detection, but their diagnostic validation remains incomplete. This study aimed to multidimensionally validate these RFs in patients with left ventricular thickening (LVT).

Methods

Prospective registry study including all patients with LVT and standardized workup at tertiary amyloidosis center. For validated RFs, “high-risk” (specificity for ATTR-CM>90%) and “low-risk” (false-negative rate<5%) findings were predefined.

Results

425 patients (321 ATTR-CM,104 control group) were included. Heart failure (97%) and polyneuropathies (78%) were among most sensitive clinical findings, while bilateral carpal tunnel syndrome (bCTS) was more specific (80%) but less sensitive (45%). Diverse ECG changes were common, yet mostly unspecific. Marked elevations of NT-proBNP and troponin were most discriminative among non-imaging RFs (Youden’s index[YI]:59%). Apical sparing (Apical-to-Basal-strain-ratio≥2.0) was the most effective, stage-independent echocardiographic parameter (YI62%), followed by biatrial enlargement, advanced diastolic dysfunction, and LVGLS impairment (YI48-55%). Normal ECG without conduction disorders history and normal levels of both NT-proBNP and hs-troponin-T constituted “low-risk” findings. Heart failure with concomitant bCTS, peripheral low voltage, right ventricular dysfunction, 5-5-5 sign, restrictive filling pattern and apical sparing with LVGLS impairment represented “high-risk” RFs. Contrary to most non-imaging RFs, most echocardiographic RFs showed association with advancing disease stage (p<0.05). All aforementioned RFs were associated with ATTR-CM independently of age, sex, and LVT-severity (p<0.05).

Conclusions

ATTR-CM is frequently associated with validated RFs that differ in their diagnostic characteristics, which should be considered when evaluating for ATTR-CM.

Schlagwörter

Stichwörter der Autor:innen

ATTR cardiomyopathycardiac amyloidosisimagingmultimodalityred flagsvalidation

Autor:innen und Institutionen

  • Deutsches Herzzentrum der Charité (DHZC), Department of Cardiology, Angiology and Intensive Care Medicine, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany.
  • Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany.
  • Amyloidosis Center Charité Berlin (ACCB), Amyloidosis Center of Charité, Campus Charité Mitte, Campus Benjamin Franklin and Campus Virchow Klinikum.
  • DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany.
  • Charité Universitätsmedizin Berlin - corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Campus Berlin-Buch, Experimental and Clinical Research Center (ECRC) - corporate member of Charité Un…
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

ORCID-Profile: Jakub Piwowarski, Jan Gröschel, Jeanette Schulz-Menger, Isabel Mattig, Friedrich Koehler, Gerhard Hindricks, Sebastian Spethmann

Zitieren

APA

Piwowarski, J., Gröschel, J., Romero Dorta, E., Schulz-Menger, J., Mattig, I., Zernikow, J., Wetz, C., von Landenberg-Roberg, V., Heidecker, B., Werhahn, S. M., Wetzel, P. J., Wieder, N. W., Pernice, H., Koehler, F., Hindricks, G., Hahn, K., Barzen, G., & Spethmann, S. (2026). Multimodal Validation and Disease Stage Dependency of ATTR Cardiomyopathy Red Flags in Patients With LV Thickening. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag285

Vancouver

Piwowarski J, Gröschel J, Romero Dorta E, Schulz-Menger J, Mattig I, Zernikow J, et al. Multimodal Validation and Disease Stage Dependency of ATTR Cardiomyopathy Red Flags in Patients With LV Thickening. ESC Heart Failure. 2026. doi:10.1093/eschf/xvag285

BibTeX
@article{Piwowarski2026,
  author = {Piwowarski, Jakub and Gröschel, Jan and Romero Dorta, Elena and Schulz-Menger, Jeanette and Mattig, Isabel and Zernikow, Jasmin and Wetz, Christoph and von Landenberg-Roberg, Vera and Heidecker, Bettina and Werhahn, Stefanie M and Wetzel, Paul J and Wieder, Nicolas W and Pernice, Helena and Koehler, Friedrich and Hindricks, Gerhard and Hahn, Katrin and Barzen, Gina and Spethmann, Sebastian},
  title = {Multimodal Validation and Disease Stage Dependency of ATTR Cardiomyopathy Red Flags in Patients With LV Thickening},
  journal = {ESC Heart Failure},
  year = {2026},
  doi = {10.1093/eschf/xvag285}
}
Kostenlos starten →